GENEVA, July 1 -- OCMS BIO, LLC filed a patent application (US2025/048310) for “RSV-TARGETING ANTIBODIES”. With publication no. WO/2026/073044, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: A61K 39/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....